LV10107A - Peptida atvasinajums ta iegusanas metode to satuross farmaceitisks sastavs un glaukomas arstesanas metode - Google Patents

Peptida atvasinajums ta iegusanas metode to satuross farmaceitisks sastavs un glaukomas arstesanas metode

Info

Publication number
LV10107A
LV10107A LV920320A LV920320A LV10107A LV 10107 A LV10107 A LV 10107A LV 920320 A LV920320 A LV 920320A LV 920320 A LV920320 A LV 920320A LV 10107 A LV10107 A LV 10107A
Authority
LV
Latvia
Prior art keywords
pct
treating glaucoma
composition
peptide
derivation methods
Prior art date
Application number
LV920320A
Other languages
English (en)
Other versions
LV10107B (en
Inventor
Stig Aasmul-Olsen
Kailash Gauri
Fred Widmer
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of LV10107A publication Critical patent/LV10107A/lv
Publication of LV10107B publication Critical patent/LV10107B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LVP-92-320A 1989-12-07 1992-12-17 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome LV10107B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
PCT/DK1990/000322 WO1991009053A1 (en) 1989-12-07 1990-12-07 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma

Publications (2)

Publication Number Publication Date
LV10107A true LV10107A (lv) 1994-05-10
LV10107B LV10107B (en) 1995-02-20

Family

ID=8147734

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-320A LV10107B (en) 1989-12-07 1992-12-17 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome

Country Status (12)

Country Link
US (1) US5411942A (lv)
EP (1) EP0504207B1 (lv)
JP (1) JPH05504336A (lv)
KR (1) KR927003631A (lv)
AT (1) ATE149517T1 (lv)
CA (1) CA2069449A1 (lv)
DE (1) DE69030100D1 (lv)
DK (1) DK167813B1 (lv)
FI (1) FI922620A (lv)
HU (1) HUT61322A (lv)
LV (1) LV10107B (lv)
WO (1) WO1991009053A1 (lv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
US5968904A (en) * 1993-06-04 1999-10-19 Demegen, Inc. Modified arginine containing lytic peptides and method of making the same by glyoxylation
ES2303338T3 (es) 1995-06-07 2008-08-01 Glaxo Group Limited Peptidos y compuestos que se unen a un receptor de trombopoyetina.
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US8283315B2 (en) * 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
AU2003275077B2 (en) 2002-09-18 2010-02-04 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
US20040171554A1 (en) * 2003-02-07 2004-09-02 Genentech, Inc. Compositions and methods for enhancing apoptosis
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
RS56387B1 (sr) * 2003-08-28 2017-12-29 Ortho Mcneil Pharm Inc Peptidi i jedinjenja koja se vežu za trombopoetinski receptor
EP1740173A4 (en) * 2004-03-23 2009-05-27 Genentech Inc AZABICYCLOOCTAN IAP INHIBITORS
CN1964970B (zh) 2004-04-07 2011-08-03 诺瓦提斯公司 Iap的抑制剂
DK1778718T3 (da) * 2004-07-02 2014-11-10 Genentech Inc Iap-inhibitorer
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
NZ589670A (en) 2004-12-20 2013-01-25 Genentech Inc Pyrrolidine inhibitors of iap
CN101374829A (zh) * 2005-12-19 2009-02-25 健泰科生物技术公司 Iap的抑制剂
PE20110218A1 (es) * 2006-08-02 2011-04-01 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
AU2007337104A1 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Imidazopyridine inhibitors of IAP
PT2137655E (pt) * 2007-04-16 2012-09-14 Momenta Pharmaceuticals Inc Produtos de glicoproteína definidos e métodos relacionados
WO2008134679A1 (en) * 2007-04-30 2008-11-06 Genentech, Inc. Inhibitors of iap
ES2398791T3 (es) * 2008-01-11 2013-03-21 Genentech, Inc. Inhibidores de IAP
EP2318395A4 (en) 2008-08-02 2011-10-26 Genentech Inc IPA INHIBITORS
NZ590500A (en) * 2008-08-16 2012-06-29 Genentech Inc Azaindole inhibitors of iap
BR112012025645A2 (pt) 2010-04-07 2017-12-12 Momenta Pharmaceuticals Inc glicanos de alta manose.
EP2686671A4 (en) 2011-03-12 2015-06-24 Momenta Pharmaceuticals Inc N-GLYCANES CONTAINING N-ACETYLHEXOSAMINE IN GLYCOPROTEIN PRODUCTS
US9695244B2 (en) 2012-06-01 2017-07-04 Momenta Pharmaceuticals, Inc. Methods related to denosumab
WO2014149067A1 (en) 2013-03-15 2014-09-25 Momenta Pharmaceuticals, Inc. Methods related to ctla4-fc fusion proteins
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457489A (en) * 1981-07-13 1984-07-03 Gilmore Samuel E Subsea fluid conduit connections for remote controlled valves
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4559340A (en) * 1983-11-25 1985-12-17 Schering Corporation Antihypertensive agents
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3661339D1 (en) * 1985-01-18 1989-01-12 Gauri Kailash Kumar Protein hydrolysates, production process and drugs containing th em
IL86386A0 (en) * 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DK615889D0 (da) 1989-12-07
FI922620A0 (fi) 1992-06-05
FI922620A (fi) 1992-06-05
HUT61322A (en) 1992-12-28
ATE149517T1 (de) 1997-03-15
EP0504207A1 (en) 1992-09-23
DK615889A (da) 1991-06-08
DE69030100D1 (de) 1997-04-10
EP0504207B1 (en) 1997-03-05
JPH05504336A (ja) 1993-07-08
DK167813B1 (da) 1993-12-20
HU9201883D0 (en) 1992-09-28
AU6898991A (en) 1991-07-18
LV10107B (en) 1995-02-20
AU636427B2 (en) 1993-04-29
US5411942A (en) 1995-05-02
WO1991009053A1 (en) 1991-06-27
KR927003631A (ko) 1992-12-18
CA2069449A1 (en) 1991-06-08

Similar Documents

Publication Publication Date Title
LV10107A (lv) Peptida atvasinajums ta iegusanas metode to satuross farmaceitisks sastavs un glaukomas arstesanas metode
FI890508A (fi) Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
HUT51136A (en) Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component
MY135057A (en) Dolastatin 15 derivatives
SE9101838D0 (sv) Novel peptides and their use
DE69420872T2 (de) Hgh enthaltende pharmazeutische zubereitungen
ATE113056T1 (de) Künstliche rezeptor-analoge.
ZA931677B (en) Process for the preparation of beta-phenylisoserine and analogues thereof
KR880000468A (ko) 아미노산 유도체의 제조방법
HUT61485A (en) Process for producing drug composition suitable for treating thrombocytopenia
DK1074264T3 (da) Inhibitorer for neovaskularisering
DE59409413D1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE25984T1 (de) Pharmakologisch aktive peptide.
NO922229L (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
AU4664489A (en) Ancrod proteins, their production and use
NZ516372A (en) Method for stabilising proteins in complex mixtures during their storage in aqueous solvents
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
SE9401480L (sv) En ny 78-resters polypeptid (NK-lysin) och dess användning